Purpose: To assess a correlation between the shrinkage of the fibroid and the course of the symptoms. Material and methods: Fourteen patients with symptomatic uterine leiomyomas (mean fibroid volume: 111.45 cm3) underwent percutaneous microwave ablation. Contrast-enhanced MRI follow- up was performed before and after treatment to evaluate the volume shrinkage. Two scores obtained from the Uterine Fibroids Symptom and Quality of Life questionnaire were used to perform a clinical follow-up to evaluate the symptoms and the quality of life at baseline, and at 3, 6 and 12months after treatment. Results: All patients were treated, no complications occurred. During a mean MR follow-up of 8.1months we observed shrinkage of the fibroids in all patients (mean 70.3cm3). During 12months clinical follow-up, we observed a significant improvement of symptoms and an excellent improvement of quality of life (p<.001). Conclusion: Uterine fibroids percutaneous microwave ablation is a safe tool to obtain a significant improvement in quality of life for all the patients of our cohort.
Percutaneous microwave ablation of uterine fibroids: correlation between shrinkage and trend symptoms / A. Maria Ierardi, M. Petrillo, E.M. Fumarola, A. Coppola, S.A. Angileri, E. Garanzini, S. Silipigni, F. Pesapane, A.M. Marconi, G. Carrafiello. - In: MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES. - ISSN 1364-5706. - 30:1(2021), pp. 33-39. [10.1080/13645706.2019.1668417]
Percutaneous microwave ablation of uterine fibroids: correlation between shrinkage and trend symptoms
E.M. Fumarola;S.A. Angileri;E. Garanzini;F. Pesapane;A.M. MarconiPenultimo
;G. Carrafiello
Ultimo
2021
Abstract
Purpose: To assess a correlation between the shrinkage of the fibroid and the course of the symptoms. Material and methods: Fourteen patients with symptomatic uterine leiomyomas (mean fibroid volume: 111.45 cm3) underwent percutaneous microwave ablation. Contrast-enhanced MRI follow- up was performed before and after treatment to evaluate the volume shrinkage. Two scores obtained from the Uterine Fibroids Symptom and Quality of Life questionnaire were used to perform a clinical follow-up to evaluate the symptoms and the quality of life at baseline, and at 3, 6 and 12months after treatment. Results: All patients were treated, no complications occurred. During a mean MR follow-up of 8.1months we observed shrinkage of the fibroids in all patients (mean 70.3cm3). During 12months clinical follow-up, we observed a significant improvement of symptoms and an excellent improvement of quality of life (p<.001). Conclusion: Uterine fibroids percutaneous microwave ablation is a safe tool to obtain a significant improvement in quality of life for all the patients of our cohort.File | Dimensione | Formato | |
---|---|---|---|
2019 - Ablation fibroids - Min Inv Ther Allied Technology.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
2.07 MB
Formato
Adobe PDF
|
2.07 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.